Arlington Trust’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Arlington Trust's JNJ Position: Q2 2026 in Review
Arlington Trust reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $28K and leaving 771 shares worth $196K. The position accounts for 0.02% of the portfolio, ranked #118.
Arlington Trust first reported a position in JNJ in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.93M in Q3 2023. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Arlington Trust held 771 shares of Johnson & Johnson worth $196K as of Q2 2026.
- Arlington Trust sold 120 Johnson & Johnson shares in Q2 2026, an estimated $28K.
- Johnson & Johnson made up 0.02% of Arlington Trust's portfolio in Q2 2026, its #118 holding.
- Arlington Trust first reported a position in Johnson & Johnson in Q3 2023 and has held it in 12 quarters since.
- Arlington Trust's Johnson & Johnson position peaked at $2.93M in Q3 2023.
- 4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.